News
New medicines have made weight loss easier than ever. But if you also want health and happiness, make these seven psychology ...
Obesity has become a global epidemic, contributing to a host of chronic health conditions such as type 2 diabetes, hypertension, and cardiovascular ...
In a recent study published in Life Metabolism, researchers at Fudan University report that even after stopping the anti-obesity drug tirzepatide, ...
22h
Flow Space on MSNIs This the Secret to Maintaining a Healthy Weight in Menopause?Menopause can feel like one big balancing act. Between managing your hormone levels and symptoms like hot flashes, night ...
15h
News-Medical.Net on MSNCan one drug do it all? Reviewing the expanding clinical universe of GLP-1 agonistsLandmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...
Q2 2025 has demonstrated the pharmaceutical industry’s continued momentum in developing transformative therapies across ...
Apnimed has scored another phase 3 knockout. The Massachusetts biotech’s daily pill for obstructive sleep apnea reduced the ...
Tirzepatide was superior to semaglutide in achieving standard and intensive cardiometabolic targets among patients with type 2 diabetes.
Men receiving tirzepatide showed greater reductions in body weight and waist circumference and improvements in erectile ...
The team found that the tirzepatide-treated mice lost about 20 percent of their body weight, mostly from reduced fat mass. In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results